Name: Ipamorelin / CJC-1295 mix 5mg+5mg
SKU: 439
Availability: InStock

Research Peptide Blend

Ipamorelin / CJC-1295 Blend 10 mg

Research-grade lyophilized peptide blend supplied in a sterile glass vial. This dual-peptide formulation contains 5 mg of Ipamorelin and 5 mg of CJC-1295 without DAC (Mod GRF 1-29), studied in controlled laboratory settings for their combined relationship to growth hormone signaling, pituitary activity, and pulsatile endocrine-response pathways.

Research Use Only

This product is intended strictly for laboratory and scientific investigation. Not for human consumption, therapeutic use, or veterinary application.

Specifications

Form

Lyophilized peptide powder

Content

5 mg Ipamorelin + 5 mg CJC-1295 (no DAC) per vial

Packaging

Sterile glass vial with secure closure

Storage

Store lyophilized at 2–8 °C, protected from light and moisture

Molecular Formula

Mixture

Molecular Weight

Mixture

Ipamorelin Sequence

Aib-His-D-2-Nal-D-Phe-Lys-NH₂

CJC-1295 Sequence

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂

CAS Number

170851-70-4 (Ipamorelin) / 863288-34-0 (CJC-1295 no DAC)

Other Names

Mod GRF 1-29, CJC-1295 no DAC, Ipamorelin blend

Reconstitution

For diluting lyophilized peptide powders, use a sterile and suitable research solvent such as bacteriostatic water (BAC), which may help support handling stability and reduce contamination risk.

For convenient laboratory use, see Bacteriostatic Water – 10 ml.

Research Overview

This blend combines two distinct growth hormone secretagogue pathways in a single research formulation. Ipamorelin is studied for selective ghrelin receptor-mediated growth hormone release, while CJC-1295 without DAC is investigated as a GHRH analogue associated with pituitary signaling and pulsatile growth hormone dynamics. Together, they are used in laboratory settings to explore synergistic endocrine-response models. No therapeutic or clinical claims are made or implied.

Primary Research Areas

Synergistic GH Secretion Models

Experimental investigation of combined growth hormone secretagogue activity through simultaneous activation of complementary endocrine pathways.

GHS-R & GHRH Receptor Signaling

Laboratory studies focused on ghrelin receptor agonism alongside GHRH analogue signaling in pituitary and endocrine-response research.

Pituitary Function & Endocrine Balance

Research involving pituitary responsiveness, hormone-release timing, and broader endocrine coordination under controlled study conditions.

Pulsatile GH Release Research

Preclinical and laboratory models examining pulsatile growth hormone secretion dynamics and response patterns across combined secretagogue systems.

Laboratory handling note:
Lyophilized peptides are commonly reconstituted using sterile research diluents such as bacteriostatic water (BAC).

Ipamorelin / CJC-1295 mix 5mg+5mg